Vetoquinol SA (EPA:VETO)
France
· Delayed Price · Currency is EUR 79.60
+1.10 (1.40%)
At close: Mar 9, 2026
Vetoquinol Revenue
Vetoquinol had revenue of 257.63M EUR in the half year ending June 30, 2025, with 0.54% growth. This brings the company's revenue in the last twelve months to 532.39M, down -0.95% year-over-year. In the year 2024, Vetoquinol had annual revenue of 539.20M with 1.88% growth.
Revenue (ttm)
532.39M
Revenue Growth
-0.95%
P/S Ratio
1.74
Revenue / Employee
213.21K
Employees
2,497
Market Cap
925.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 539.20M | 9.93M | 1.88% |
| Dec 31, 2023 | 529.27M | -10.51M | -1.95% |
| Dec 31, 2022 | 539.78M | 18.51M | 3.55% |
| Dec 31, 2021 | 521.27M | 93.81M | 21.94% |
| Dec 31, 2020 | 427.47M | 31.48M | 7.95% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| Nanobiotix | 10.16M |
| Clariane SE | 5.31B |
| Ramsay Générale de Santé | 5.32B |
| DBV Technologies | 4.69M |
Vetoquinol News
- 6 months ago - Vetoquinol SA 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 6 months ago - Vetoquinol SA reports 1H results - Seeking Alpha